These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21321558)

  • 1. Prevention of vascular calcification: is pyrophosphate therapy a solution?
    Persy VP; McKee MD
    Kidney Int; 2011 Mar; 79(5):490-3. PubMed ID: 21321558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with pyrophosphate inhibits uremic vascular calcification.
    O'Neill WC; Lomashvili KA; Malluche HH; Faugere MC; Riser BL
    Kidney Int; 2011 Mar; 79(5):512-7. PubMed ID: 21124302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification.
    Lomashvili KA; Garg P; Narisawa S; Millan JL; O'Neill WC
    Kidney Int; 2008 May; 73(9):1024-30. PubMed ID: 18288101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench.
    El-Abbadi M; Giachelli CM
    Curr Opin Nephrol Hypertens; 2005 Nov; 14(6):519-24. PubMed ID: 16205469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does any therapy exist for vascular calcifications in uremia?
    Mazzaferro S; Pasquali M; Rotondi S; Tartaglione L
    J Nephrol; 2011; 24 Suppl 18():S16-24. PubMed ID: 21623578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
    Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V
    Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of arterial calcification: spotlight on the inhibitors.
    Weissen-Plenz G; Nitschke Y; Rutsch F
    Adv Clin Chem; 2008; 46():263-93. PubMed ID: 19004192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone pyrophosphate in uremia and its association with extraosseous calcification.
    Alfrey AC; Solomons CC
    J Clin Invest; 1976 Mar; 57(3):700-5. PubMed ID: 175092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraosseous calcification. Evidence for abnormal pyrophosphate metabolism in uremia.
    Alfrey AC; Solomons CC; Ciricillo J; Miller NL
    J Clin Invest; 1976 Mar; 57(3):692-9. PubMed ID: 175091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for alkaline phosphatase as an inducer of vascular calcification in renal failure?
    Schoppet M; Shanahan CM
    Kidney Int; 2008 May; 73(9):989-91. PubMed ID: 18414436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular calcification and uremia: what do we know?
    Cozzolino M; Mazzaferro S; Pugliese F; Brancaccio D
    Am J Nephrol; 2008; 28(2):339-46. PubMed ID: 18046081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pyrophosphate and mineralization (TNSALP, PC-1, ANK)].
    Kaji H
    Clin Calcium; 2007 Oct; 17(10):1574-9. PubMed ID: 17906411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of the mechanism for vascular calcification in chronic kidney disease].
    Persy V
    Verh K Acad Geneeskd Belg; 2008; 70(4):285-303. PubMed ID: 19166100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease.
    Yamada S; Taniguchi M; Tokumoto M; Toyonaga J; Fujisaki K; Suehiro T; Noguchi H; Iida M; Tsuruya K; Kitazono T
    J Bone Miner Res; 2012 Feb; 27(2):474-85. PubMed ID: 21987400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin.
    Lomashvili KA; Cobbs S; Hennigar RA; Hardcastle KI; O'Neill WC
    J Am Soc Nephrol; 2004 Jun; 15(6):1392-401. PubMed ID: 15153550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular calcification: lessons from scientific models.
    Sinha S; Eddington H; Kalra PA
    J Ren Care; 2009 Mar; 35 Suppl 1():51-6. PubMed ID: 19222732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrophosphate, alkaline phosphatase, and vascular calcification.
    O'Neill WC
    Circ Res; 2006 Jul; 99(2):e2. PubMed ID: 16857967
    [No Abstract]   [Full Text] [Related]  

  • 18. Uremic vascular calcification.
    Chen NX; Moe SM
    J Investig Med; 2006 Nov; 54(7):380-4. PubMed ID: 17169259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells.
    Chen NX; O'Neill KD; Duan D; Moe SM
    Kidney Int; 2002 Nov; 62(5):1724-31. PubMed ID: 12371973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?
    Neven EG; De Broe ME; D'Haese PC
    Kidney Int; 2009 Mar; 75(6):580-2. PubMed ID: 19247382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.